Cogent Biosciences, Inc. Earnings Per Share, Basic and Diluted
Cogent Biosciences, Inc. (COGT) reported Earnings Per Share, Basic and Diluted of -$0.68 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-10
- Cogent Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.68.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.60.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.48.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.43.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for fiscal 2021 was -$1.87.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for fiscal 2020 was -$16.17.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for fiscal 2019 was -$4.18.
- Cogent Biosciences, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.39.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | -$0.68 10-Q · filed 2022-05-10 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.77 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$2.21 derived: net income ÷ weighted average shares · filed 2024-02-26 | ||||
| 2021-12-31 | -$0.60 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.51 derived: net income ÷ weighted average shares · filed 2024-02-26 | -$1.87 10-K · filed 2022-03-15 | ||||
| 2021-09-30 | -$0.48 10-Q · filed 2021-11-10 | -$0.91 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$1.25 10-Q · filed 2021-11-10 | -$4.93 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||||
| 2021-06-30 | -$0.43 10-Q · filed 2021-08-16 | -$0.77 10-Q · filed 2021-08-16 | -$4.67 derived: net income ÷ weighted average shares · filed 2022-08-09 | -$7.58 derived: net income ÷ weighted average shares · filed 2022-08-09 | ||||
| 2021-03-31 | -$0.34 10-Q · filed 2022-05-10 | -$4.72 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$8.33 derived: net income ÷ weighted average shares · filed 2022-05-10 | -$10.32 derived: net income ÷ weighted average shares · filed 2022-05-10 | ||||
| 2020-12-31 | -$6.04 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$11.43 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$14.12 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$16.17 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | -$5.07 10-Q · filed 2021-11-10 | -$6.51 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$7.56 10-Q · filed 2021-11-10 | -$7.45 derived: net income ÷ weighted average shares · filed 2021-11-10 | ||||
| 2020-06-30 | -$0.95 10-Q · filed 2021-08-16 | -$0.24 10-Q · filed 2020-08-11 | -$1.76 10-Q · filed 2021-08-16 | -$0.44 10-Q · filed 2020-08-11 | -$1.46 derived: net income ÷ weighted average shares · filed 2021-08-16 | -$3.02 derived: net income ÷ weighted average shares · filed 2021-08-16 | ||
| 2020-03-31 | -$0.81 10-Q · filed 2021-05-12 | -$0.20 10-Q · filed 2020-05-11 | -$0.50 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$2.06 derived: net income ÷ weighted average shares · filed 2021-05-12 | -$1.97 derived: net income ÷ weighted average shares · filed 2021-05-12 | |||
| 2019-12-31 | $0.30 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$1.26 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$1.32 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$4.18 10-K · filed 2021-03-16 | -$1.04 10-K · filed 2020-03-26 | |||
| 2019-09-30 | -$1.56 10-Q · filed 2020-11-09 | -$0.39 10-Q · filed 2019-11-12 | -$1.18 derived: net income ÷ weighted average shares · filed 2020-11-09 | -$4.49 10-Q · filed 2020-11-09 | -$1.12 10-Q · filed 2019-11-12 | -$1.74 derived: net income ÷ weighted average shares · filed 2020-11-09 | ||
| 2019-06-30 | -$0.34 10-Q · filed 2020-08-11 | -$0.73 10-Q · filed 2020-08-11 | -$1.02 derived: net income ÷ weighted average shares · filed 2020-08-11 | -$1.36 derived: net income ÷ weighted average shares · filed 2020-08-11 | ||||
| 2019-03-31 | -$0.39 10-Q · filed 2020-05-11 | -$0.67 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$1.02 derived: net income ÷ weighted average shares · filed 2020-05-11 | -$1.33 derived: net income ÷ weighted average shares · filed 2020-05-11 | ||||
| 2018-12-31 | -$0.29 10-K · filed 2019-03-28 | -$0.63 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$0.94 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$1.39 10-K · filed 2020-03-26 | ||||
| 2018-09-30 | -$0.34 10-Q · filed 2019-11-12 | -$0.65 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$1.12 10-Q · filed 2019-11-12 | -$1.64 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2018-06-30 | -$0.31 10-Q · filed 2019-08-12 | -$0.80 10-Q · filed 2019-08-12 | -$1.36 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$1.97 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2018-03-31 | -$0.66 10-Q · filed 2019-05-13 | -$1.32 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$2.01 derived: net income ÷ weighted average shares · filed 2020-03-26 | -$2.58 derived: net income ÷ weighted average shares · filed 2020-03-26 | ||||
| 2017-12-31 | -$0.66 10-K · filed 2019-03-28 | -$1.35 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$1.92 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$2.51 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$0.69 10-K · filed 2019-03-28 | -$1.27 derived: net income ÷ weighted average shares · filed 2019-03-28 | -$1.85 10-Q · filed 2018-11-13 | |||||
| 2017-06-30 | -$0.58 10-K · filed 2019-03-28 | -$1.16 10-Q · filed 2018-08-13 | ||||||
| 2017-03-31 | -$0.58 10-K · filed 2019-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |